Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Johnson City, Tenn.-based Crown Laboratories must halt the manufacturing and distribution of various prescription and over-the-counter skin creams following a complaint filed by the Department of Justice on behalf of the Food and Drug Administration.
San Francisco-based McKesson released its financial results for the first quarter of fiscal year 2018, which ended June 30.
Here are six articles published by Becker's Hospital Review this week, featuring Salt Lake City-based Intermountain Healthcare's adoption of a needle-free blood draw technology, the 10 most popular prescription drugs in 2017 and more.
Salt Lake City-based Intermountain Healthcare is implementing a needle-free technology to improve the blood draw experience for inpatients across its 22 hospitals.
Cantrell Drug Co. issued a voluntary recall of all lots of its unexpired sterile drug products due to a lack of sterility assurance.
Congressional Democrats announced their "Better Deal" campaign Monday, which outlines three major goals: raise Americans' wages, lower their cost of living and build a better economy.
The Food and Drug Administration on Monday expanded approval for Bristol-Myers Squibb's cancer drug Yervoy to treat pediatric populations.
The Food and Drug Administration on Monday approved Lupin's fluocinonide topical skin cream.
The possibility of Amazon expanding its services into digital health has many industry insiders worried, according to CNBC.
Health systems will see a 7.61 percent price increase for drug purchases in 2018, according to estimates from Vizient's July 2017 Drug Price Forecast.